Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_assertion description "[ChoK? specific inhibitors, MN58b and TCD-717, have demonstrated a potent antitumoral activity both in vitro and in vivo against several tumor-derived cell line xenografts including CRC-derived cell lines.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_assertion evidence source_evidence_literature NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_assertion SIO_000772 23762272 NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_assertion wasDerivedFrom befree-2016 NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_assertion wasGeneratedBy ECO_0000203 NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.
- befree-2016 importedOn "2016-02-19" NP1085547.RAAoClcQ80qnbm6UqsxtKPm9ueSH5l4ZyblJ3T5T44YYs130_provenance.